(S)-(+)-4-Phenyl-2-oxazolidinone | CAS:99395-88-7

We serve (S)-(+)-4-Phenyl-2-oxazolidinone CAS:99395-88-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(S)-(+)-4-Phenyl-2-oxazolidinone

Chemical Name:(S)-(+)-4-Phenyl-2-oxazolidinone
CAS.NO:99395-88-7
Synonyms:(S)-(+)-4-Phenyl-2-oxazolidinone
(S)-4-Phenyl-2-Oxazolidione
S-4-PHENYL-OXAZOLIDIN-2-ONE
(4S)-PHENYL-2-OXAZOLIDINONE
4-phenyl-2-0xazolidinone
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 407.0±25.0 °C at 760 mmHg
Melting Point 130-133ºC
Molecular Formula C9H9NO2
Molecular Weight 163.173
Flash Point 200.0±23.2 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.548
 
Specification:
Appearance:White to light yellow crystalline powder
Assay(HPLC):≥99.0%
Single impurity:≤0.5%
Total impurities:≤1.0%
Chiral Assay(GC)≥99.5%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ezetimibe(CAS:163222-33-1).



Contact us for information like (S)-(+)-4-Phenyl-2-oxazolidinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-phenyl-2-0xazolidinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-phenyl-2-0xazolidinone Use and application,4-phenyl-2-0xazolidinone technical grade,usp/ep/jp grade.


Related News: Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.2-FLUOROPHENYL ISOTHIOCYANATE manufacturer Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.2-deoxy-D-ribose supplier A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).2-Bromo-4-methylpyridine vendor The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.